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Background
Neuropsychiatric disorders are one of the main challenges
of human medicine with epilepsy as one of the most com-
mon and serious disorders of the brain. Temporal lobe
epilepsy represents the most common type of epilepsies
and is often accompanied by marked neuronal degenera-
tion. One main factor that causes neural loss is the excito-
toxicity of glutamate, which is copiously released during
seizures and hypoxia accompanying seizures. There is evi-
dence that endogenous opioids, namely dynorphin (Dyn),
act as modulators of neuronal excitability. It was also
shown that the deletion of proDyn in mice and low
expression in humans is associated with increased epilepsy
vulnerability. Dyn targets opioid receptors and in particu-
lar the  opioid receptor (KOP). The KOP receptors in the
hippocampal formation are located in very strategically
points for the control of the glutamate release and most
important they are not altered under epileptic conditions.
Interestingly, proDyn expression is reduced after an initial
increase in most epilepsy models and activation of KOP
receptors may be neuroprotective. Still, the functional
background of these neuroprotective effects is not fully
understood. The aim of this study was to investigate
the influence of KOP agonists and antagonists on EEG
patterns of epileptic mice.
Methods
Kainic acid (KA; 3 nmol in 50 nL saline) was injected uni-
laterally into the dorsal hippocampus, causing acute and
delayed behavioral and EEG effects. Four-channel EEG
traces were recorded from ipsi-and controlateral hippo-
campi and motorcortices applying depth and surface elec-
trodes, respectively. The KOP-specific agonist U-50,488H
and antagonist GNTI were dissolved in saline (adjusted to
pH 7.4) and applied i.p. or intracisternally, respectively.
Results
Sharp waves and paroxysmal discharges in the ipsilateral
hippocampus were recorded about 2 weeks after KA
injection. Paroxysmal discharges were accompanied by
behavioral arrest and stereotypic behaviour like head
nodding. Application of KOP agonists at different doses
(2, 5, 10 mg/kg) markedly reduced paroxysmal dis-
charges. In contrast, the KOP antagonist (3 nmol) pro-
longed the duration of such discharges. These data
represent observations from preliminary experiments.
Conclusion
Data collected so far confirm the anticonvulsant action
of KOP agonists in the subchronical phase of epilepsy,
suggesting that neuroprotective effects are indeed due to
reduced seizure activity.
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